Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

German launch for bisphosphonate

Dec. 31, 1996

Positive phase III results reported for Ergoset monotherapy

Dec. 24, 1996

Androsorb cleared for clinical trials

Dec. 23, 1996

ImClone and Immunex crosslicense flt3/flk-2 technology

Dec. 23, 1996

Third approval for Parke-Davis HMG-CoA reductase inhibitor

Dec. 23, 1996

Fujisawa synthesizes novel bone resorption inhibitors

Dec. 20, 1996

Grelan, Fournier collaborate on ACAT inhibitors

Dec. 20, 1996

Shaman and Ono expand diabetes collaboration

Dec. 18, 1996

Pamidronate effective against skeletal complications in breast cancer patients

Dec. 18, 1996

Troglitazone hypotensive, hypoglycemic activities established in preclinical model

Dec. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...